Morgan Stanley analyst Dara Mohsenian upgraded e.l.f. Beauty shares to overweight from equal weight, citing compelling valuation and outsized growth potential.
E.l.f. Beauty shares look a lot more attractive after their 2024 sell-off, according to Morgan Stanley . Analyst Dara Mohsenian upgraded shares of the cosmetics stock to overweight from equal weight. Mohsenian also hiked his price target by $14 to $153, suggesting upside of almost 23% in the coming 12 months compared to last week's close.
'Valuation looks compelling relative to outsized growth potential after a sharp pullback in the stock in H2 of 2024,' Mohsenian wrote to clients in a Monday note. Mohsenian noted that the stock is trading at roughly half of its recent highs. Shares finished 2024 down 13%, marking its first losing year since 2018, after trading above $218 last June. Shares briefly rose as much as 2.5% on Monday following the upgrade. Mohsenian's call marks a reversal after downgrading e.l.f. to equal weight about a year ago. That move was due to concerns around outsized valuations, he said, as well as difficult sales comparisons and risks tied to tariffs. Now, Mohsenian said those overhangs have mostly abated. Additionally, the analyst said his call becomes even stronger when considering the lackluster outlook for other makers of consumer staples
Finance ELF BEAUTY MORGAN STANLEY PRICE TARGET UPGRADE ANALYST
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Morgan Stanley Sees 53% Upside in Hims & Hers StockAnalyst Craig Hettenbach initiated coverage of Hims & Hers Health with an overweight rating and $42 price target, citing strong growth prospects in mental health, weight loss, and dermatology treatments.
Read more »
Morgan Stanley sees these 3 Asian stocks as 'actionable ideas'Morgan Stanley sees these 3 Asian stocks as 'actionable ideas'
Read more »
Morgan Stanley CIO Sees Interest Rates as Key Driver for Stocks in 2025Morgan Stanley's Chief Investment Officer Michael Wilson believes that rising interest rates, particularly the 10-year yield surpassing 4.50%, will significantly influence stock performance in 2025.
Read more »
Morgan Stanley Sees 28% Upside for RHMorgan Stanley analyst Simeon Gutman upgraded RH to overweight from equal-weight and raised his price target, citing a strong year for the company and the potential for growth in 2024 and 2025.
Read more »
Morgan Stanley turns negative on red hot Palantir, predicts 25% pullbackThe Wall Street investment bank anticipates a rocky road ahead for shares of Palantir after a record 2024 run fueled by artificial intelligence.
Read more »
Morgan Stanley Favors Quality Stocks Amid Rising Treasury YieldsMorgan Stanley advises investors to prioritize quality stocks as 10-year Treasury yields climb, driven by expectations of a less dovish Federal Reserve and increased term premium. This shift in bond yields has triggered a negative correlation with equity returns, prompting the firm to highlight interest rates as a key variable to monitor in early 2025.
Read more »